Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Clinical trial NCT05867563 · UNKNOWN

Trial details

NCT number: NCT05867563
Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm

Start date: 2023-07-04
Primary completion: 2025-05-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.